Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).

Yann NeuzilletJean-Pierre RaynaudCamélia RadulescuJean FietFranck GitonJean-François DreyfusTarek P GhoneimThierry LebretHenry Botto

Published in: The Prostate (2017)

STERPROSER trial provides evidence for higher DHT concentration in highvolume prostates, that could reflect either higher 5-alpha reductase expression or lower expression of downstream metabolizing enzymes such as 3a-hydoxysteroid dehydrogenase.

Keyphrases

benign prostatic hyperplasia
poor prognosis
study protocol
phase iii
clinical trial
prostate cancer
endothelial cells
phase ii
long non coding rna
randomized controlled trial
mental health
induced pluripotent stem cells